InvestorsHub Logo
Followers 23
Posts 2523
Boards Moderated 0
Alias Born 10/26/2003

Re: PhrmaBro post# 30073

Saturday, 06/05/2021 1:13:20 AM

Saturday, June 05, 2021 1:13:20 AM

Post# of 42415

Emergent will provide access to manufacturing capacity reserved for and provided by the U.S. government under Humanigen’s Cooperative Research and Development Agreement (CRADA) with the Department of Defense’s (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services.

Providing "access to manufacturing capacity"... Manufacturing capacity isn't the issue... It's production ready capacity, which this is not. It'll take 6-12 months to get any capacity production ready.

Management continues stating 100k treatments in 12 months...